Psychedelic Science 2023

Attending this event?

Psychedelic Science 2023

10:15am MDT

A History & Outlook on Psychedelic Research TBA

10:45am MDT

What Will People Think? Revealing Public Knowledge, Belief, and Perceptions of Psychedelics TBA

12:00pm MDT

Who is blind in psychedelic research? TBA

12:15pm MDT

Assessing the evidence for microdosing TBA

2:30pm MDT

Magnesium-Ibogaine: the Stanford Traumatic Injury to the CNS (MISTIC) Protocol – A Pilot Study in Special Operations Veterans with Traumatic Brain Injuries TBA

2:45pm MDT

Preliminary results from a Pilot study of the efficacy and safety of ibogaine in the treatment of methadone detoxification TBA

3:45pm MDT

Increasing safety and participation in psychedelic research and communities among people of the global majority and gender/sexually expansive people TBA

5:15pm MDT

Preparing for inspections of trial sites by the FDA TBA

10:15am MDT

Effects of Psilocybin-Facilitated Experience on Religious Leaders: Quantitative and Qualitative Findings from the Johns Hopkins and NYU study TBA

12:00pm MDT

Naturalistic Psilocybin Use is Associated with Persisting Improvements in Mental Health and Well-being in a Large Prospective Sample TBA

12:30pm MDT

Wellness and Psychedelics: Exploring the Data from 3000+ Individuals TBA

2:30pm MDT

Improving study design in trials using psychedelic-assisted therapies TBA

4:00pm MDT

Group administration and integration in psychedelic therapy TBA

5:15pm MDT

Borderline Personality Disorder and the potential of psychedelic-assisted therapy TBA

5:45pm MDT

Psychedelics & Psychosis: The Latest Science TBA

6:00pm MDT

Family Matters in Psychedelic Therapy: Maximizing Positive Outcomes and Minimizing Systemic Distress TBA

10:15am MDT

5-MeO-DMT as a mental health tool: exploring possible mechanisms of action, the reactivation phenomenon, and some ethical considerations regarding the Sonoran Desert toad TBA

10:45am MDT

From observational research to therapeutic applications: 5-MeO-DMT TBA

12:00pm MDT

Psilocybin administration for therapist training: outcomes from a world-first trial TBA

12:30pm MDT

Breaking Patterns and Finding Meaning: A Study on Low-Dose LSD TBA

2:30pm MDT

Magnesium-Ibogaine: the Stanford Traumatic Injury to the CNS (MISTIC) Protocol – A Pilot Study in Special Operations Veterans with Traumatic Brain Injuries Colorado Convention Center Psychedelic Outcomes: Intersection of Environment, Self-Identity, and Success ( The POIESIS Study) TBA

2:45pm MDT

Psychedelics as relational medicines: Investigating the role of psychosocial factors for outcomes of clinical and naturalistic psychedelic use TBA

3:00pm MDT

Effects of psilocybin-assisted psychotherapy on personality and their relationship with self-compassion among individuals with alcohol use disorder TBA

3:15pm MDT

Psychedelic Personality Change: Observations, Mechanisms, and Limitations TBA

3:45pm MDT

Mental well-being changes in older adults attending ceremonial psychedelic group sessions TBA

4:00pm MDT

The Love Project: Preliminary outcomes of a survey study among psychedelic users TBA

4:15pm MDT

Psychedelics and Sexual Functioning: a Mixed-Method Study in Healthy and Depressed Subjects TBA

4:30pm MDT

Psychedelics during the global crisis: 3 years of longitudinal assessments TBA